Policy & Key Advocacy Topics
Explore our legislative priorities, supporting research, and advocacy tools designed to protect patient access to care.
HR 4299
Studies & Analytics
Milliman Cost Analysis
Analysis of the IRA’s impact on Part B provider reimbursement and patient access.
Avalere Analysis on Commercial Spillover
Evaluates the broader spillover effects of IRA Part B negotiation on the commercial market.
Avalere Provider Survey on Part B Negotiation Impacts
Evaluates how Medicare Part B drug price negotiations may impact provider reimbursement, prescribing behavior, and patient access to treatments based on provider-reported expectations.
Survivors For Solutions
Evaluates how proposed Medicare Part B reimbursement cuts could impact patient access to treatments and the sustainability of provider practices.
Op-Eds & Commentary
Congress Must Safeguard Access to Infusion Treatments
Santa Fe New Mexican
A recent opinion piece highlights the importance of maintaining access to infusion-based therapies and the role of providers in ensuring continuity of care.
Inflation Reduction Act Unfair to Patients and Physicians
The Washington Times — July 1, 2026
Wayne Winegarden, Ph.D., calls on Congress to address the IRA’s patient-access challenges.
Medicare Is Pushing Lifesaving Drugs Out of Physician Offices—and Older Patients Will Suffer
Medical Economics — July 6, 2026
Reps. Greg Murphy and Adam Gray advocate for the Protecting Patient Access to Cancer and Complex Therapies Act.
Let Doctors Choose the Right Medical Treatments
RealClearHealth — July 8, 2026
Dr. Robert Levin calls for action on H.R. 4299 to maintain patients’ access to treatment.
Patients Lose When Washington Underpays
The Washington Post — July 28, 2026
Dr. Angus Worthing highlights the importance of adequate reimbursement to providing patient treatment.
Cancer Care Is Getting Harder for Missourians. Congress, Make This Fix
The Kansas City Star — August 5, 2026
Former Missouri House Speaker Ken Jones calls on Congress to pass H.R. 4299.
Congress Must Act to Protect Patient Access to Cancer Care
RealClearHealth — August 13, 2026
Former Congressman Dr. Michael Burgess aligns with providers in calling on Congress to ensure patients retain access to negotiated medicines.
Protecting Patient Access to Care Must Remain a Congressional Priority
NorthJersey.com
This commentary underscores the need for legislative action to prevent unintended consequences that could limit access to essential treatments.
Congress Must Act to Protect Healthcare Access Under the Inflation Reduction Act
Washington Examiner
This commentary emphasizes the need for legislative action to address reimbursement changes that could threaten physician sustainability and limit patient access to care.